Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
665
NCT00952445
A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2003
Completion: Jun 30, 2004
NCT00631007
A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator
Start: Feb 29, 2008
Completion: Sep 30, 2009
NCT02638038
This is a Randomized Study Comparing Two Doses of INT131 ( 3 mg and 1 mg) Administered Orally (PO) Daily (QD) Versus Placebo 1 Tablet PO QD in Subjects With Treatment-naïve RRMS for ≤ 3 Years
Start: Feb 28, 2015
Completion: Dec 12, 2016